Open original FDA record ↗Recall record
- FDA identifier
- Z-0162-2027
- Company in FDA record
- Magellan Diagnostics, Inc.
- FDA classification date
- Oct 15, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
In kit sub-lot 2530M-01 the date of expiration printed on the outer labeling may indicate the wrong expiration date of July 22, 2026 while the correct expiration date is July 13, 2026. If used the system will display an error message and prevent the operator from running the test. Resulting in delayed results.
Source facts
- Action
- Magellan notified consignees on about September 4, 2026, via telephone call indicating a written notification of the recall would follow. On 09/17/2026, a notification letter was emailed to consignees with the following instructions: 1. Complete, sign, and return the CONFIRMATION OF NOTIFICATION FORM. 2. Review your inventory for the affected LeadCare II Blood Lead Test Kit lot identified. 3. Immediately discontinue use of any remaining affected kits. 4. Return any recalled product still in your possession to Magellan Diagnostics, Inc. for destruction.
- Initiated
- 2026-09-04
- Root cause
- Labeling Change Control
- Distribution
- US Nationwide distribution in the states of CA, IN, PA, TX, NE, IL, MA, MO, KY.
- Recall number
- Z-0162-2027
- Recall status
- Open, Classified
- CDRH record ID
- 222454
- FDA classified
- 2026-10-15
- Recall event number
- 99776